Goldman Sachs’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Other funds holding OYST
Goldman Sachs's OYST Position: Q1 2023 in Review
Goldman Sachs sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 18,261 shares — an estimated $204K sold.
Goldman Sachs first reported a position in OYST in Q2 2020 and held it in 11 quarters. The position peaked at $2.18M in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.
- Goldman Sachs reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Goldman Sachs sold 18,261 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $204K.
- Goldman Sachs first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
- Goldman Sachs's Oyster Point Pharma, Inc. Common Stock position peaked at $2.18M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.
Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.